Keyphrases
Breast Cancer
100%
Task Force Report
100%
HER2 Testing
100%
HER2 mutation
100%
Fluorescence in Situ Hybridization
62%
Immunohistochemistry
50%
Human Epidermal Growth Factor Receptor 2 (HER2)
50%
Tumor
37%
Neoadjuvant Setting
37%
Metastatic Setting
37%
Gene Copy number
37%
HER2 Status
37%
HER2-positive
25%
OR Genes
25%
Gene Amplification
25%
Predictive Factors
25%
Chromosome 17
25%
HER2 Expression
25%
Epidemiology
12%
Medical Oncology
12%
Surgical Oncology
12%
Radiation Oncology
12%
Clinical Trials
12%
Patient Care
12%
Clinical Decision-making
12%
Clinical Application
12%
Patient Assessment
12%
Pathologic
12%
Evidence-based
12%
Hybrid Method
12%
Sensitivity Specificity
12%
Targeted Therapy
12%
Breast Cancer Patients
12%
Invasive Breast Cancer
12%
Tumor Samples
12%
Breast Tumor
12%
Trastuzumab
12%
Multidisciplinary Panel
12%
Surgical Patients
12%
Patient Advocacy
12%
Breast Cancer Treatment
12%
Prognostic Factors
12%
Testing Method
12%
Prognostic Information
12%
Test Validity
12%
Formal Validation
12%
Predictive Information
12%
Cancer Panel
12%
Consensus Approach
12%
Individual Tasks
12%
Concordance Test
12%
Surgical Epidemiology
12%
Quality Control Assurance
12%
Medicine and Dentistry
Breast Cancer
100%
Neoplasm
62%
Fluorescence in Situ Hybridization
62%
Immunohistochemistry
50%
Chromosome 17
25%
Gene Amplification
25%
Predictive Factor
25%
Sensitivity and Specificity
12%
Cohort Effect
12%
Prognostic Factor
12%
Cancer Epidemiology
12%
Oncology Pathology
12%
Surgical Oncology
12%
Radiation Oncology
12%
Medical Oncology
12%
Clinical Trial
12%
Targeted Therapy
12%
Patient Advocacy
12%
Clinical Decision Making
12%
Trastuzumab
12%